Results 231 to 240 of about 78,174 (316)

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu   +11 more
wiley   +1 more source

Pediatric Oncology Nursing Competencies in Latin America and the Caribbean: A Scoping Review to Inform Practice, Education, and Research

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Nurses are central to cancer care for children and adolescents, yet no comprehensive synthesis has defined essential core competencies for pediatric oncology nursing (PON) practice internationally, particularly in Latin America and the Caribbean (LAC).
Luís Carlos Lopes‐Júnior   +7 more
wiley   +1 more source

Uncovering gaps in HIV care in belgium through patient reported outcome measures and neurocognitive screening. [PDF]

open access: yesDiscov Ment Health
Vanden Bulcke C   +5 more
europepmc   +1 more source

Financial Toxicity Associated with Biological Medicines: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 81-93, July 2026.
Financial toxicity, defined as the economic burden experienced by patients due to medication and other healthcare costs and their consequences, such as material, psychosocial and behavioral effects, represents a significant concern for individuals receiving biological medicines.
Laura Sara Maria Saarukka   +4 more
wiley   +1 more source

Athletic Intervention After Thoracic Surgery for Lung Cancer: Rationale and Design of the ATHENA Study

open access: yesHealth Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background The optimal therapeutic approach for early‐stage NSCLC (I–II, and, in some specific cases, IIIa) is lung resective surgery with mediastinal lymphadenectomy. However, it should be remarked that lung resection surgery further negatively affects respiratory muscle function and health‐related quality of life (HRQoL).
Giulia M. Stella   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy